Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen

Vaccine

Volumn 29, Issue 7, 2011, Pages 1514-1518

  Every, Alison L ^a   Stent, Andrew ^a   Moloney, Margaret B ^b   Ng, Garrett Z ^a   Skene, Caroline D ^a   Edwards, Stirling J ^b   Sutton, Philip ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

Author keywords

Helicobacter pylori; Superoxide dismutase; Vaccine antigen

Indexed keywords

ANTIBODY; HELICOBACTER PYLORI VACCINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; ESCHERICHIA COLI; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, HUMORAL; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE;

EID: 79151481297     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.019     Document Type: Article

References (21)

1. Kandulski A., Selgrad M., Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008, 40(August (8)):619-626.
2. Bagchi D., Bhattacharya G., Stohs S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996, 24(June (6)):439-450.
3. Ramarao N., Gray-Owen S.D., Meyer T.F. Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol 2000, 38(October (1)):103-113.
4. Allen L.A., Beecher B.R., Lynch J.T., Rohner O.V., Wittine L.M. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 2005, 174(March (6)):3658-3667.
5. Davies G.R., Simmonds N.J., Stevens T.R., Sheaff M.T., Banatvala N., Laurenson I.F., et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994, 35(February (2)):179-185.
6. Ernst F.D., Homuth G., Stoof J., Mader U., Waidner B., Kuipers E.J., et al. Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur. J Bacteriol 2005, 187(June (11)):3687-3692.
7. Wang G., Alamuri P., Maier R.J. The diverse antioxidant systems of Helicobacter pylori. Mol Microbiol 2006, 61(August (4)):847-860.
8. Seyler R.W., Olson J.W., Maier R.J. Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun 2001, 69(June (6)):4034-4040.
9. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., Dixon M.F. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997, 112(April (4)):1386-1397.
10. Alm R.A., Ling L.S.L., Moir D.T., King B.L., Brown E.D., Doig P.C., et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999, 397(6715):176-180.
11. Sutton P., Wilson J., Lee A. Further development of the Helicobacter pylori mouse vaccination model. Vaccine 2000, 18(24):2677-2685.
12. Harbour S.N., Every A.L., Edwards S., Sutton P. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge. Helicobacter 2008, 13(December (6)):494-499.
13. Skene C.D., Doidge C., Sutton P. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori. Vaccine 2008, 26(July (31)):3880-3884.
14. Sutton P. Considering increased mouse stomach mass, when calculating prophylactic vaccine efficacy against Helicobacter pylori. Helicobacter 2007, 12:210-212.
15. Graham D.Y., Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol 2008, 5(June (6)):321-331.
16. Harris A.G., Wilson J.E., Danon S.J., Dixon M.F., Donegan K., Hazell S.L., et al. (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology 2003, 149(March (Pt 3)):665-672.
17. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998, 188(December (12)):2277-2288.
18. Sutton P., Doidge C., Pinczower G., Wilson J., Harbour S., Swierczak A., et al. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol Med Microbiol 2007, 50(July (2)):213-219.
19. Radcliff F.J., Hazell S.L., Kolesnikow T., Doidge C., Lee A., Catalase a novel antigen for Helicobacter pylori vaccination. Infect Immun 1997, 65(11):4668-4674.
20. Ferrero R.L., Thiberge J.M., Kansau I., Wuscher N., Huerre M., Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995, 92(14):6499-6503.
21. Miao L., St Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009, 47(August (4)):344-356.